Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity

Purpose: This study aimed to report on our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the treatment of adrenal gland metastases. Specifically, we examined the outcomes and toxicity from this treatment modality on adjacent organs at risk. Methods and Materia...

Full description

Bibliographic Details
Main Authors:	Diego A.S. Toesca, MD, Amanda J. Koong, Rie von Eyben, MSc, Albert C. Koong, MD, PhD, Daniel T. Chang, MD
Format:	Article
Language:	English
Published:	Elsevier 2018-10-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109418300848

Similar Items

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
by: Amanda J. Koong, et al.
Published: (2017-01-01)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
by: Cyrielle Scouarnec, et al.
Published: (2019-08-01)

Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation
by: Margaret M. Kozak, MD, et al.
Published: (2020-01-01)

Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases
by: Matthew Mills, et al.
Published: (2024-03-01)

Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis
by: C. Yuste, et al.
Published: (2024-03-01)

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
by: Theresa Voglhuber, et al.
Published: (2020-06-01)

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer
by: Bichun Xu, et al.
Published: (2023-01-01)

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer
by: Xianzhi Zhao, et al.
Published: (2018-10-01)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
by: Morgan Michalet, et al.
Published: (2022-12-01)

A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone Metastases
by: Joyce H. Lee, BA, et al.
Published: (2024-04-01)

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity
by: Rachel B. Jimenez, MD, et al.
Published: (2017-07-01)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
by: Antonio Pontoriero MD, et al.
Published: (2020-04-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases
by: Nihaal Mehta, BA, et al.
Published: (2018-07-01)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
by: Matthew Chan, MD, FRCPC, et al.
Published: (2021-01-01)

Stereotactic body radiation therapy for colorectal liver metastases
by: Issa Mohamad, et al.
Published: (2022-12-01)

Effect of Immunotherapy and Stereotactic Body Radiation Therapy Sequencing on Local Control and Survival in Patients With Spine Metastases
by: Jacob Eckstein, MD, et al.
Published: (2023-05-01)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
by: Robert W. Gao, BS, et al.
Published: (2019-04-01)

Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis
by: Xuehong Liao, et al.
Published: (2023-11-01)

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
by: Alexander L. Chin, MD, MBA, et al.
Published: (2018-07-01)

SBRT to adrenal metastases provides high local control with minimal toxicity
by: Kristin Plichta, MD, PhD, et al.
Published: (2017-10-01)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
by: Suneetha Devpura, PhD, et al.
Published: (2021-11-01)

The role of stereotactic body radiation therapy in the treatment of colorectal liver metastases
by: Marinković Mladen, et al.
Published: (2022-01-01)

MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases
by: Austin J. Sim, et al.
Published: (2020-11-01)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
by: Ingrid Digernes, MSc, et al.
Published: (2018-10-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases
by: Ahmed Hadj Henni PhD, et al.
Published: (2023-10-01)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
by: Irina M. Cazacu, et al.
Published: (2023-11-01)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
by: Shalini Moningi, MD, et al.
Published: (2021-03-01)

Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases
by: Esther N.D. Kok, et al.
Published: (2020-01-01)

Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases
by: Gamze Ugurluer, et al.
Published: (2024-05-01)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
by: John R. van Sörnsen de Koste, et al.
Published: (2021-10-01)

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
by: Nathaniel Scher, et al.
Published: (2019-09-01)

Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases
by: Laura Burgess, et al.
Published: (2024-03-01)

Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases
by: Berber T, et al.
Published: (2022-08-01)

Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors
by: Rachelle eLanciano, et al.
Published: (2012-03-01)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
by: J. John Lucido, PhD, et al.
Published: (2022-11-01)

The Novel Use of Stereotactic Radiotherapy for Remnant Adrenal Tissue in Nelson Syndrome
by: Alexandra N. Martirossian, MD, et al.
Published: (2020-01-01)